{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T19:14:24Z","timestamp":1779909264416,"version":"3.53.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:00:00Z","timestamp":1672963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:00:00Z","timestamp":1672963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Mesorectal motion (MM) is a source of uncertainty during neoadjuvant chemoradiotherapy (nCRT) delivery for locally advanced rectal cancer (LARC). Previously published experiences using cone-beam computed tomography imaging have already described significant movement. Aim of this analysis is to assess inter-fraction MM using the higher tissue contrast provided by hybrid magnetic resonance imaging (MRI) in LARC patients (pts) treated with MRI guided radiation therapy (MRgRT).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The total mesorectum, its superior (Msup), middle (Mmid) and lower (Mlow) regions were contoured on the positioning MRIs acquired on simulation day and on each treatment day. Six PTVs were obtained adding 0.5, 0.7, 1, 1.3, 1.5 and 2\u00a0cm margin to the whole mesorectum, starting from the simulation MRI. Margins including 95% of the mesorectal structures during whole treatment in 95% of patients (pts) were considered adequate.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total number of 312 fractions of 12 consecutive pts was retrospectively analyzed. The different mesorectum regions show specific motion variability. In particular, Msup shows larger variability in left, right and anterior directions, while the Mlow in caudal and posterior ones. The anterior margin is significantly larger in the Msup than in the other regions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Different mesorectal regions move differently throughout the radiotherapy treatment, with the largest MM in the Msup anterior direction. Asymmetrical margins are recommended.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13014-022-02193-1","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T04:34:34Z","timestamp":1672979674000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Mesorectal motion evaluation in rectal cancer MR-guided radiotherapy: an exploratory study to quantify treatment margins"],"prefix":"10.1186","volume":"18","author":[{"given":"Luca","family":"Boldrini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuditta","family":"Chiloiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Cusumano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Placidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Turco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Valerio","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Nardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Galetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Indovina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Antonietta","family":"Gambacorta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,6]]},"reference":[{"key":"2193_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1748-717X-5-17","volume":"5","author":"L Arbea","year":"2010","unstructured":"Arbea L, Ramos LI, Mart\u00ednez-Monge R, Moreno M, Aristu J. Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): dosimetric comparison and clinical implications. Radiat Oncol. 2010;5:17.","journal-title":"Radiat Oncol"},{"key":"2193_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.radonc.2014.08.035","volume":"113","author":"JPM Burbach","year":"2014","unstructured":"Burbach JPM, den Harder AM, Intven M, van Vulpen M, Verkooijen HM, Reerink O. Impact of radiotherapy boost on pathological complete response in patients with locally advanced rectal cancer: a systematic review and meta-analysis. Radiother Oncol. 2014;113:1\u20139.","journal-title":"Radiother Oncol"},{"key":"2193_CR3","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.clon.2011.07.012","volume":"24","author":"S Gwynne","year":"2012","unstructured":"Gwynne S, Webster R, Adams R, Mukherjee S, Coles B, Staffurth J. Image-guided radiotherapy for rectal cancer: a systematic review. Clin Oncol (R Coll Radiol). 2012;24:250\u201360.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"2193_CR4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.radonc.2016.07.017","volume":"120","author":"V Valentini","year":"2016","unstructured":"Valentini V, Gambacorta MA, Barbaro B, Chiloiro G, Coco C, Das P, et al. International consensus guidelines on clinical target volume delineation in rectal cancer. Radiother Oncol. 2016;120:195\u2013201.","journal-title":"Radiother Oncol"},{"key":"2193_CR5","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1080\/02841860802256459","volume":"47","author":"E Ippolito","year":"2008","unstructured":"Ippolito E, Mertens I, Haustermans K, Gambacorta MA, Pasini D, Valentini V. IGRT in rectal cancer. Acta Oncol. 2008;47:1317\u201324.","journal-title":"Acta Oncol"},{"key":"2193_CR6","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s11547-020-01193-z","volume":"126","author":"C Rosa","year":"2021","unstructured":"Rosa C, Caravatta L, Di Tommaso M, Fasciolo D, Gasparini L, Di Guglielmo FC, et al. Cone-beam computed tomography for organ motion evaluation in locally advanced rectal cancer patients. Radiol Med. 2021;126:147\u201354.","journal-title":"Radiol Med"},{"key":"2193_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.prro.2010.11.006","volume":"1","author":"ME Daly","year":"2011","unstructured":"Daly ME, Murphy JD, Mok E, Christman-Skieller C, Koong AC, Chang DT. Rectal and bladder deformation and displacement during preoperative radiotherapy for rectal cancer: are current margin guidelines adequate for conformal therapy? Pract Radiat Oncol. 2011;1:85\u201394.","journal-title":"Pract Radiat Oncol"},{"key":"2193_CR8","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/jrr\/rrz092","volume":"61","author":"ZA Alickikus","year":"2020","unstructured":"Alickikus ZA, Kuru A, Aydin B, Akcay D, Gorken IB. The importance of mesorectum motion in determining PTV margins in rectal cancer patients treated with neoadjuvant radiotherapy. J Radiat Res. 2020;61:335\u201342.","journal-title":"J Radiat Res"},{"key":"2193_CR9","doi-asserted-by":"publisher","first-page":"e431","DOI":"10.1016\/j.ijrobp.2011.04.060","volume":"81","author":"I Chong","year":"2011","unstructured":"Chong I, Hawkins M, Hansen V, Thomas K, McNair H, O\u2019Neill B, et al. Quantification of organ motion during chemoradiotherapy of rectal cancer using cone-beam computed tomography. Int J Radiation Oncol Biol Phys. 2011;81:e431-8.","journal-title":"Int J Radiation Oncol Biol Phys"},{"key":"2193_CR10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13014-014-0311-6","volume":"10","author":"H Yamashita","year":"2015","unstructured":"Yamashita H, Takenaka R, Sakumi A, Haga A, Otomo K, Nakagawa K. Analysis of motion of the rectum during preoperative intensity modulated radiation therapy for rectal cancer using cone-beam computed tomography. Radiat Oncol. 2015;10:2.","journal-title":"Radiat Oncol"},{"key":"2193_CR11","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0360-3016(02)02753-0","volume":"53","author":"JJ Nuyttens","year":"2002","unstructured":"Nuyttens JJ, Robertson JM, Yan D, Martinez A. The variability of the clinical target volume for rectal cancer due to internal organ motion during adjuvant treatment. Int J Radiat Oncol Biol Phys. 2002;53:497\u2013503.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2193_CR12","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1259\/bjr\/66311683","volume":"80","author":"SD Allen","year":"2007","unstructured":"Allen SD, Gada V, Blunt DM. Variation of mesorectal volume with abdominal fat volume in patients with rectal carcinoma: assessment with MRI. Br J Radiol. 2007;80:242\u20137.","journal-title":"Br J Radiol"},{"key":"2193_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s13304-019-00689-2","volume":"72","author":"R Peltrini","year":"2020","unstructured":"Peltrini R, Sacco M, Luglio G, Bucci L. Local excision following chemoradiotherapy in T2-T3 rectal cancer: current status and critical appraisal. Updates Surg. 2020;72:29\u201337.","journal-title":"Updates Surg"},{"key":"2193_CR14","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S2468-1253(17)30074-2","volume":"2","author":"F Dossa","year":"2017","unstructured":"Dossa F, Chesney TR, Acuna SA, Baxter NN. A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2017;2:501\u201313.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2193_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13014-019-1308-y","volume":"14","author":"S Corradini","year":"2019","unstructured":"Corradini S, Alongi F, Andratschke N, Belka C, Boldrini L, Cellini F, et al. MR-guidance in clinical reality: current treatment challenges and future perspectives. Radiat Oncol. 2019;14:92.","journal-title":"Radiat Oncol"},{"key":"2193_CR16","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.3390\/cancers14071643","volume":"14","author":"E Meldolesi","year":"2022","unstructured":"Meldolesi E, Chiloiro G, Giannini R, Menghi R, Persiani R, Corvari B, et al. The role of simultaneous integrated boost in locally advanced rectal cancer patients with positive lateral pelvic lymph nodes. Cancers (Basel). 2022;14:1643.","journal-title":"Cancers (Basel)"},{"key":"2193_CR17","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/S1470-2045(15)00159-X","volume":"16","author":"C R\u00f6del","year":"2015","unstructured":"R\u00f6del C, Graeven U, Fietkau R, Hohenberger W, Hothorn T, Arnold D, et al. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the german CAO\/ARO\/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 2015;16:979\u201389.","journal-title":"Lancet Oncol"},{"key":"2193_CR18","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ctro.2019.04.006","volume":"18","author":"G Chiloiro","year":"2019","unstructured":"Chiloiro G, Boldrini L, Meldolesi E, Re A, Cellini F, Cusumano D, et al. MR-guided radiotherapy in rectal cancer: first clinical experience of an innovative technology. Clin Transl Radiat Oncol. 2019;18:80\u20136.","journal-title":"Clin Transl Radiat Oncol"},{"key":"2193_CR19","doi-asserted-by":"publisher","first-page":"iv22","DOI":"10.1093\/annonc\/mdx224","volume":"28","author":"R Glynne-Jones","year":"2017","unstructured":"Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, R\u00f6del C, Cervantes A, et al. Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up\u2020. Ann Oncol Elsevier. 2017;28:iv22-40.","journal-title":"Ann Oncol Elsevier"},{"key":"2193_CR20","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.ijrobp.2011.12.058","volume":"83","author":"M Ng","year":"2012","unstructured":"Ng M, Leong T, Chander S, Chu J, Kneebone A, Carroll S, et al. Australasian gastrointestinal trials Group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer. Int J Radiat Oncol Biol Phys. 2012;83:1455\u201362.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2193_CR21","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/S0140-6736(09)60485-2","volume":"373","author":"P Quirke","year":"2009","unstructured":"Quirke P, Steele R, Monson J, Grieve R, Khanna S, Couture J, et al. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet. 2009;373:821\u20138.","journal-title":"Lancet"},{"key":"2193_CR22","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.radonc.2009.04.022","volume":"92","author":"J Nijkamp","year":"2009","unstructured":"Nijkamp J, de Jong R, Sonke J-J, Remeijer P, van Vliet C, Marijnen C. Target volume shape variation during hypo-fractionated preoperative irradiation of rectal cancer patients. Radiother Oncol. 2009;92:202\u20139.","journal-title":"Radiother Oncol"},{"key":"2193_CR23","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1002\/bjs.7180","volume":"97","author":"M Kusters","year":"2010","unstructured":"Kusters M, Wallner C, Lange MM, DeRuiter MC, van de Velde CJH, Moriya Y, et al. Origin of presacral local recurrence after rectal cancer treatment. Br J Surg. 2010;97:1582\u20137.","journal-title":"Br J Surg"},{"key":"2193_CR24","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.ijrobp.2008.02.032","volume":"71","author":"K Tournel","year":"2008","unstructured":"Tournel K, De Ridder M, Engels B, Bijdekerke P, Fierens Y, Duchateau M, et al. Assessment of intrafractional movement and internal motion in radiotherapy of rectal cancer using megavoltage computed tomography. Int J Radiat Oncol Biol Phys. 2008;71:934\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2193_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ijrobp.2010.01.042","volume":"80","author":"JD Brierley","year":"2011","unstructured":"Brierley JD, Dawson LA, Sampson E, Bayley A, Scott S, Moseley JL, et al. Rectal motion in patients receiving preoperative radiotherapy for carcinoma of the rectum. Int J Radiat Oncol Biol Phys. 2011;80:97\u2013102.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2193_CR26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13063-015-0586-4","volume":"16","author":"JPM Burbach","year":"2015","unstructured":"Burbach JPM, Verkooijen HM, Intven M, Kleijnen J-PJE, Bosman ME, Raaymakers BW, et al. RandomizEd controlled trial for pre-operative dose-escalation BOOST in locally advanced rectal cancer (RECTAL BOOST study): study protocol for a randomized controlled trial. Trials. 2015;16:58.","journal-title":"Trials"},{"key":"2193_CR27","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1080\/0284186X.2018.1532598","volume":"58","author":"J-PJE Kleijnen","year":"2019","unstructured":"Kleijnen J-PJE, van Asselen B, Van den Begin R, Intven M, Burbach JPM, Reerink O, et al. MRI-based tumor inter-fraction motion statistics for rectal cancer boost radiotherapy. Acta Oncol. 2019;58:232\u20136.","journal-title":"Acta Oncol"},{"key":"2193_CR28","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.radonc.2021.07.011","volume":"162","author":"H Eijkelenkamp","year":"2021","unstructured":"Eijkelenkamp H, Boekhoff MR, Verweij ME, Peters FP, Meijer GJ, Intven MPW. Planning target volume margin assessment for online adaptive MR-guided dose-escalation in rectal cancer on a 1.5 T MR-Linac. Radiother Oncol. 2021;162:150\u20135.","journal-title":"Radiother Oncol"},{"key":"2193_CR29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12885-021-09158-9","volume":"22","author":"G Chiloiro","year":"2022","unstructured":"Chiloiro G, Cusumano D, Boldrini L, Romano A, Placidi L, Nardini M, et al. THUNDER 2: THeragnostic Utilities for neoplastic DisEases of the rectum by MRI guided radiotherapy. BMC Cancer. 2022;22:67.","journal-title":"BMC Cancer"},{"key":"2193_CR30","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ctro.2019.04.005","volume":"18","author":"C Gani","year":"2019","unstructured":"Gani C, Boldrini L, Valentini V. Online MR guided radiotherapy for rectal cancer. New opportunities. Clin Transl Radiat Oncol. 2019;18:66\u20137.","journal-title":"Clin Transl Radiat Oncol"},{"key":"2193_CR31","doi-asserted-by":"crossref","unstructured":"Intven MPW, de Mol van Otterloo SR, Mook S, Doornaert PAH, de Groot-van Breugel EN, Sikkes GG, et al. Online adaptive MR-guided radiotherapy for rectal cancer; feasibility of the workflow on a 1.5T MR-linac: clinical implementation and initial experience. Radiother Oncol. 2021;154:172\u20138.","DOI":"10.1016\/j.radonc.2020.09.024"},{"key":"2193_CR32","doi-asserted-by":"publisher","first-page":"619852","DOI":"10.3389\/fonc.2021.619852","volume":"11","author":"L Boldrini","year":"2021","unstructured":"Boldrini L, Intven M, Bassetti M, Valentini V, Gani C. MR-Guided radiotherapy for rectal cancer: current perspective on organ preservation. Front Oncol. 2021;11:619852.","journal-title":"Front Oncol"},{"key":"2193_CR33","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1007\/s00330-005-2657-5","volume":"15","author":"MR Torkzad","year":"2005","unstructured":"Torkzad MR, Blomqvist L. The mesorectum: morphometric assessment with magnetic resonance imaging. Eur Radiol. 2005;15:1184\u201391.","journal-title":"Eur Radiol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-022-02193-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-022-02193-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-022-02193-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T04:38:53Z","timestamp":1672979933000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-022-02193-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,6]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2193"],"URL":"https:\/\/doi.org\/10.1186\/s13014-022-02193-1","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,6]]},"assertion":[{"value":"4 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research study was conducted retrospectively in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients recruited in the study will sign informed consent regarding publishing their data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Luca Boldrini and Dr. Davide Cusumano have active research agreements with ViewRay Inc (Mountain View, CA, USA) and received speaker honoraria for scientific presentations and travel reimbursements. Dr. Lorenzo Placidi reports a consulting agreement and research grants with ViewRay, outside the submitted work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}